Source:http://linkedlifedata.com/resource/umls/id/C0064113
MSH: A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis.,CSP: orally active antimycotic; structurally related to ketoconazole.,NCI: A drug used to prevent or treat fungal infections. It belongs to the family of drugs called antifungal agents.,PDQ: A synthetic triazole agent with antimycotic properties. Formulated for both topical and systemic use, itraconazole preferentially inhibits fugal cytochrome P450 enzymes, resulting in a decrease in fungal ergosterol synthesis. Because of its low toxicity profile, this agent can be used for long-term maintenance treatment of chronic fungal infections. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39106&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=39106&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C1138" NCI Thesaurus),NCI: A synthetic t